Home / Import refusals / SCS-0475966-0/11/4

FDA Import Refusal SCS-0475966-0/11/4 — Bayer Healthcare Pharmaceuticals Inc.

Bayer Healthcare Pharmaceuticals Inc. — FEI 2243252

The FDA refused shipment SCS-0475966-0/11/4 from Bayer Healthcare Pharmaceuticals Inc. (United States) on June 19, 2020. The refused product falls under Drugs and Biologics — ASPIRIN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 19, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
60LAA05 ASPIRIN (ANALGESIC)
Charges
75

Recent inspections

  • 1286004 (NAI Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1277153 (NAI Fri Aug 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1251837 (NAI Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1196111 (NAI Wed Feb 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1153395 (NAI Wed Sep 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-6429231-1/11/1 (Mon Jan 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0256520-8/11/1 (Thu Jan 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • AEK-6264407-2/11/1 (Mon Sep 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-0147820-6/11/1 (Mon Aug 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2900582-1/11/1 (Fri Feb 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)

FDA data resources